Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer Biomet is a global leader in musculoskeletal healthcare. It designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants; and related surgical products.
345 E Main St
Warsaw, Indiana 46580-2746
Phone: 15742676131
www.zimmerbiomet.com
Zimmer Biomet to acquire AI surgical guidance company OrthoGrid Systems hlandi Fri, 08/09/2024 - 11:41
We recently compiled a list of the 10 Best Cosmetic Surgery and Aesthetics Stocks To Buy. In this article, we are going to take a look at where Zimmer Biomet Holdings, Inc. (NYSE:ZBH) stands against the other cosmetic surgery and aesthetics stocks. While imperfections are inherent to being human, aesthetic (or cosmetic) plastic surgery is a […]
Decoding Zimmer Biomet Holdings Inc (ZBH): A Strategic SWOT Insight
Zimmer Biomet President and CEO Ivan Tornos sits down with ''Mad Money'' host Jim Cramer to talk quarterly results.
No summary available.
Zimmer Biomet Holdings (NYSE: ZBH ) just reported results for the second quarter of 2024. Zimmer Biomet Holdings reported earnings per share of $2.01. This was above the analyst estimate for EPS of $1.99. The company reported revenue of $1.94 billion. This was 0.10% better than the analyst estimate for revenue of $1.94 billion. InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at editor@investorplace.com. More From InvestorPlace Legendary Investor Predicts: “Forget AI… THIS Technology Is the Future” The post ZBH Stock Earnings: Zimmer Biomet Holdings Beats EPS, Beats Revenue for Q2 2024 appeared first on InvestorPlace .
Zimmer Biomet''s second quarter sales reached $1.9 billion, according to financial results posted Aug. 7.
https://www.investing.com/news/stock-market-news/zimmer-biomet-beats-profit-estimates-on-strong-demand-for-medical-devices-3559261
